查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547765

全球透皮皮肤贴片市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Transdermal Skin Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球透皮皮肤贴片市场需求预计将从 2023 年的 84.1 亿美元达到 2032 年近 133 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.23%。

透皮贴片是透皮技术的一种。它是一种贴在皮肤上的含药贴剂，可提供特定剂量的药物。这些贴片使用扩散技术透过皮肤提供药物剂量，随后在很长一段时间内释放到血液中。这些贴片可有效用于治疗荷尔蒙和心臟疾病。这些贴片也用于治疗偏头痛、帕金森氏症、阿兹海默症、中风、爱滋病毒、骨质疏鬆症、皮肤病相关问题和不宁腿症候群治疗。

市场动态

促进市场成长的主要因素是透皮药物相对于传统药物（胃肠道毒性药物）的优势越来越大，导致噁心和呕吐。由于它们本质上是非侵入性的，因此减少了静脉或肠胃外治疗造成的不便。主要优点是贴片通常透过覆盖药物储存的多孔膜或透过体温熔化沉积在黏合剂中的薄层药物，将药物控制释放到患者体内。此外，增加药物开发的资金和投资也促进了市场的成长。然而，皮肤无法吸收一系列活性物质预计将阻碍市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球透皮皮肤贴片市场的每个细分市场进行了包容性评估。透皮皮肤贴片产业的成长和趋势为这项研究提供了整体方法。

市场区隔

透皮皮肤贴片市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

  • 水库
  • 药物黏合剂（单层、多层）
  • 微型针
  • 矩阵
  • 其他（蒸气等）

按申请

  • 疼痛管理
  • 荷尔蒙失调
  • 减少吸烟和戒烟援助
  • 神经系统疾病
  • 心血管疾病
  • 其他（晕车、膀胱过动症等）

按销售类型

  • 处方
  • 场外交易 (OTC)

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的透皮皮肤贴片市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。透皮皮肤贴片市场的主要参与者包括Hisamitsu Pharmaceutical Co. Inc.、Viatris Inc.、Nitto Denko Corporation、Novartis AG、Luye Pharma Group、Teikoku Pharma、Samyang Holdings Corporation、Gedeon Richter PLC、AdhexPharma、Sparsha Pharma International Pvt Ltd本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：透皮贴片 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 市场吸引力分析：依应用分类
    • 按销售类型分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球透皮皮肤贴片市场分析：依产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：依产品类型
  • 水库
  • 药物黏合剂（单层、多层）
  • 微型针
  • 矩阵
  • 其他（蒸气等）

第 6 章：全球透皮皮肤贴片市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 疼痛管理
  • 荷尔蒙失调
  • 减少吸烟和戒烟援助
  • 神经系统疾病
  • 心血管疾病
  • 其他（晕车、膀胱过动症等）

第 7 章：全球透皮皮肤贴片市场分析：依销售类型

  • 按销售类型概述
  • 历史和预测数据
  • 按销售类型分析
  • 处方
  • 场外交易 (OTC)

第 8 章：全球透皮皮肤贴片市场分析：按分销管道

  • 配销通路概览
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章：全球透皮皮肤贴片市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：透皮贴片公司的竞争格局

  • 透皮皮肤贴片市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Hisamitsu Pharmaceutical Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Viatris Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Nitto Denko Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Luye Pharma Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teikoku Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Samyang Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gedeon Richter PLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AdhexPharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sparsha Pharma International Pvt Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11213473

The global demand for Transdermal Skin Patches Market is presumed to reach the market size of nearly USD 13.3 Billion by 2032 from USD 8.41 Billion in 2023 with a CAGR of 5.23% under the study period 2024-2032.

A transdermal patch is a type of transdermal technology. It is a medicated adhesive patch placed on the skin to deliver a specific dose of medication. These patches provide medication dose though the skin using the diffusion technique, which later gets released in the bloodstream over a long period. These patches are effectively used for the treatment of hormonal and cardiac disorders. These patches are also used to treat migraine, Parkinsons disease, Alzheimer's, strokes, HIV, osteoporosis, dermatology-related issues, and restless leg syndrome treatments.

MARKET DYNAMICS

The primary factor contributing to the growth of the market is the increasing advantages of transdermal medicine over the conventional way of medications (medications for gastrointestinal toxicity), resulting in nausea and vomiting. As they are non-invasive in nature, they reduce the inconvenience caused due to intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the medication into the patient, generally through either a porous membrane covering the storage of medication or through body heat melting thin layers of medication deposited in the adhesive. Additionally, increasing funding and investments for drug development boosts the market growth. However, the skin's inability to absorb a range of active substances is expected to impede the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Transdermal Skin Patches. The growth and trends of Transdermal Skin Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Transdermal Skin Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Reservoir
  • Drug-in-Adhesive (Single Layer, Multilayer)
  • Microneedle
  • Matrix
  • Others (Vapor, etc.)

By Application

  • Pain Management
  • Hormonal Disorders
  • Smoking Reduction and Cessation Aid
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others (Motion Sickness, Overactive Bladder, etc.)

By Sales Type

  • Prescription
  • Over-the-Counter (OTC)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transdermal Skin Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transdermal Skin Patches market include Hisamitsu Pharmaceutical Co. Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Teikoku Pharma, Samyang Holdings Corporation, Gedeon Richter PLC, AdhexPharma, Sparsha Pharma International Pvt Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. TRANSDERMAL SKIN PATCHES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Sales Type
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Reservoir Historic and Forecast Sales By Regions
  • 5.5. Drug-in-Adhesive (Single Layer, Multilayer) Historic and Forecast Sales By Regions
  • 5.6. Microneedle Historic and Forecast Sales By Regions
  • 5.7. Matrix Historic and Forecast Sales By Regions
  • 5.8. Others (Vapor, etc.) Historic and Forecast Sales By Regions

6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Pain Management Historic and Forecast Sales By Regions
  • 6.5. Hormonal Disorders Historic and Forecast Sales By Regions
  • 6.6. Smoking Reduction and Cessation Aid Historic and Forecast Sales By Regions
  • 6.7. Neurological Disorders Historic and Forecast Sales By Regions
  • 6.8. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 6.9. Others (Motion Sickness, Overactive Bladder, etc.) Historic and Forecast Sales By Regions

7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY SALES TYPE

  • 7.1. Overview By Sales Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Sales Type
  • 7.4. Prescription Historic and Forecast Sales By Regions
  • 7.5. Over-the-Counter (OTC) Historic and Forecast Sales By Regions

8. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TRANSDERMAL SKIN PATCHES COMPANIES

  • 10.1. Transdermal Skin Patches Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF TRANSDERMAL SKIN PATCHES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hisamitsu Pharmaceutical Co. Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Viatris Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Nitto Denko Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Novartis AG
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Luye Pharma Group
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Teikoku Pharma
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Samyang Holdings Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Gedeon Richter PLC
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. AdhexPharma
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Sparsha Pharma International Pvt Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Transdermal Skin Patches Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Transdermal Skin Patches Report
  • Market Research Process
  • Market Research Methodology
  • Global Transdermal Skin Patches Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Sales Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.